ArticleActa biochimica Polonica2026
The promise and peril of mirror bacteria.
Article in Acta biochimica Polonica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mirror bacteria are organisms constructed from mirror-image biomolecules unlike those used by all known life and are moving from theoretical concept to practical feasibility. Their unusual chemistry that makes them resistant to natural degradation and isolated from ecosystems, fuels optimism for applications such as more stable medicines, long-term information storage, and novel platforms for bioengineering. At the same time, these very characteristics raise reservations: they challenge existing definitions of "life," expose gaps in regulation, and risk undermining public trust if deployed without careful oversight. This perspective assesses not only those risks but also the opportunities of mirror bacteria, moving beyond narrow biosafety debates to explore their broader ethical, regulatory, and cultural implications. We argue that mirror bacteria represent a rare testcase for how science and society navigate the responsibilities of creating fundamentally new forms of life. Their development offers not only technical possibilities but also a chance to build more resilient frameworks for governance and ethics in synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.